Clinical Trial Update: Hematopoietic Stem Cell Therapy for Patients With Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on Phase 1/Phase 2 autologous hematopoietic stem cell therapy for multiple sclerosis; the study was terminated with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Hematopoietic Stem Cell Therapy

Snippet

Sponsor: Northwestern University | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2014-05-01